The clinical trials are planned to be conducted in Brazil. How does cancer immunotherapy work? Preclinical development is ongoing. More than 7,000 of these will prove fatal. These include cancers such as ovarian, breast, colorectal and lung cancers. PDS0103 is currently in late preclinical development. These issued patents will expire in 2031-2034, or later if patent term extension applies. DOTAP Chloride Enantiomer License Agreement with Merck Eprova AG. 20 Index The term of the CRADA is five (5) years, starting February 2, 2016. The CRADA may be terminated by either party at any time by mutual written consent. In this event, the BLA must be resubmitted with the additional information. Our approach to compliance may evolve over time in light of these types of developments. Medical data is considered sensitive data that merits stronger safeguards. As of December 31, 2020, we had 15 employees and 5 consultants. 44 Index The successful development of immunotherapies is highly uncertain. In addition, there is a natural transition period when a new CRO commences work. We expect the impact of COVID-19 on the FDA's operations will continue to evolve. The Leahy-Smith Act includes a number of significant changes to United States patent law. The changes included in the Tax Act are broad and complex.